These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 37293248)

  • 1. The need for Africa to develop capacity for vaccinology as a means of curbing antimicrobial resistance.
    Akegbe H; Onyeaka H; Michael Mazi I; Alex Olowolafe O; Dolapo Omotosho A; Olatunji Oladunjoye I; Amuda Tajudeen Y; Seun Ofeh A
    Vaccine X; 2023 Aug; 14():100320. PubMed ID: 37293248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing Vaccinology Capacity: Education and Efforts in Vaccine Development and Manufacturing across Africa.
    Sinumvayo JP; Munezero PC; Tope AT; Adeyemo RO; Bale MI; Nyandwi JB; Haakuria VM; Mutesa L; Adedeji AA
    Vaccines (Basel); 2024 Jul; 12(7):. PubMed ID: 39066380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable New Vaccine Introduction.
    Makenga G; Bonoli S; Montomoli E; Carrier T; Auerbach J
    Front Public Health; 2019; 7():56. PubMed ID: 30949465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building global vaccine manufacturing capacity: Spotlight on Africa.
    Rubin Thompson LJ; Grubo M; Veller M; Badenhorst RH; Nott J; Debruyne L; Makadzange T; Nicolaou S; Stanberry L; Sall A; James WG
    Vaccine; 2023 Jun; 41(27):4050-4056. PubMed ID: 37173266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference.
    Wiysonge CS; Waggie Z; Hawkridge A; Schoub B; Madhi SA; Rees H; Hussey G
    Pan Afr Med J; 2016; 23():53. PubMed ID: 27217879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
    Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding global vaccine manufacturing capacity: Strategic prioritization in small countries.
    Mukherjee S; Kalra K; Phelan AL
    PLOS Glob Public Health; 2023; 3(6):e0002098. PubMed ID: 37384623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa.
    Kana BD; Arbuthnot P; Botwe BK; Choonara YE; Hassan F; Louzir H; Matsoso P; Moore PL; Muhairwe A; Naidoo K; Ndomondo-Sigonda M; Madhi SA
    Lancet Infect Dis; 2023 Aug; 23(8):e288-e300. PubMed ID: 37290473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strengthening Africa's capacity for vaccine research: Needs and challenges.
    Owolade AJ; Sokunbi TO; Aremu FO; Omotosho EO; Sunday BA; Adebisi YA; Ekpenyong A; Babatunde AO
    Health Promot Perspect; 2022; 12(3):282-285. PubMed ID: 36686053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK.
    Veepanattu P; Singh S; Mendelson M; Nampoothiri V; Edathadatil F; Surendran S; Bonaconsa C; Mbamalu O; Ahuja S; Birgand G; Tarrant C; Sevdalis N; Ahmad R; Castro-Sanchez E; Holmes A; Charani E
    Int J Infect Dis; 2020 Nov; 100():278-282. PubMed ID: 32860949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curbing antimicrobial resistance in post-COVID Africa: Challenges, actions and recommendations.
    Shomuyiwa DO; Lucero-Prisno DE; Manirambona E; Suleman MH; Rayan RA; Huang J; Zaw TN; Babatunde Y; Denkyira SA; Musa SS
    Health Sci Rep; 2022 Sep; 5(5):e771. PubMed ID: 35949681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
    Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
    Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Children's Vaccine Initiative and vaccine supply: the role of the public sector.
    van Noort RB
    Vaccine; 1992; 10(13):909-10. PubMed ID: 1471410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of South Africa's public-private partnership for the localisation of vaccine research, manufacture and distribution.
    Walwyn DR; Nkolele AT
    Health Res Policy Syst; 2018 Mar; 16(1):30. PubMed ID: 29587777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory Surveillance, Quality Management, and Its Role in Addressing Antimicrobial Resistance in Africa: A Narrative Review.
    Musa K; Okoliegbe I; Abdalaziz T; Aboushady AT; Stelling J; Gould IM
    Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial stewardship in the era of the COVID-19 pandemic: A systematic review protocol on the opportunities and challenges for Sub-Saharan Africa.
    Njuma Libwea J; Ngwa CH; Ngomba AV; Wirsiy FS; Mpofu L; Ndongo CB; Koulla-Shiro S; Graham S; Djieuya LPT; Mandeng N; Mballa GAE; Sobh E; Nwaru BI; Ndombo PK; Epee E
    Medicine (Baltimore); 2023 May; 102(19):e33697. PubMed ID: 37171319
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.